Barclays
NEPH icon

Barclays’s Nephros NEPH Stock Holding History

Barclays’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96 Buy
+27
New +$88 ﹤0.01% 5197
2025
Q4 		– Sell
-106
Closed -$501 – 5536
2025
Q3 		$501 Buy
+106
New +$416 ﹤0.01% 5205

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Barclays's NEPH Position: Q2 2026 in Review

Barclays opened a new position in Nephros (NEPH) in Q2 2026: 27 shares worth $96. The stake represents ﹤0.01% of the portfolio and ranks #5197 among its holdings. This is a return to the name: Barclays previously reported a position in NEPH as recently as Q3 2025.

Barclays first reported a position in NEPH in Q3 2025 and has held it in 2 quarters since. The position peaked at $501 in Q3 2025. 33 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

  • Barclays held 27 shares of Nephros worth $96 as of Q2 2026.
  • Nephros was a new Barclays position in Q2 2026.
  • Nephros made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5197 holding.
  • Barclays first reported a position in Nephros in Q3 2025 and has held it in 2 quarters since.
  • Barclays's Nephros position peaked at $501 in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.